Immucell Corp /de/ (ICCC): Joseph H Crabb , VP & Chief Scientific Officer of Immucell Corp /de/ sold 1,935 shares on Jul 8, 2016. The Insider selling transaction was reported by the company on Jul 12, 2016 to the Securities and Exchange Commission. The shares were sold at $6.55 per share for a total value of $12,669.19 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 12, 2016, Joseph H Crabb (VP & Chief Scientific Officer) sold 1,935 shares at $6.55 per share price.
ImmuCell Corporation: On Monday, Jul 11, 2016 heightened volatility was witnessed in ImmuCell Corporation which led to swings in the share price. The shares opened for trading at $7.1339 and hit $7.162 on the upside , eventually ending the session at $6.9, with a gain of 2.22% or 0.15 points. The heightened volatility saw the trading volume jump to 5,617 shares. The 52-week high of the share price is $11.4 and the company has a market cap of $29 M . The 52-week low of the share price is at $5.6.
ImmuCell Corporation is an animal health company. The Company is engaged in the development acquisition manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing a new product that addresses mastitis. The Company’s lead product First Defense is manufactured from cows’ colostrum utilizing its vaccine and milk protein purification technologies. The Company’s Wipe Out Dairy Wipes are made from a non-woven fabric that allows for a vigorous cleaning. The Company also developed California Mastitis Test (CMT) which is used for bulk tank as well as individual cow sample monitoring and is used to determine which quarter of the udder is mastitic. The Company’s product development initiative is Mast Out a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.